Diagnosis of limb-girdle muscular dystrophy 2A by immunohistochemical techniques

dc.creatorKOLSKI, Hanna K.
dc.creatorHAWKINS, Cynthia
dc.creatorZATZ, Mayana
dc.creatorPAULA, Flavia de
dc.creatorBIGGAR, Doug
dc.creatorALMAN, Ben
dc.creatorVAJSAR, Jiri
dc.date.accessioned2012-10-20T03:06:42Z
dc.date.accessioned2018-07-04T15:33:13Z
dc.date.available2012-10-20T03:06:42Z
dc.date.available2018-07-04T15:33:13Z
dc.date.created2012-10-20T03:06:42Z
dc.date.issued2008
dc.identifierNEUROPATHOLOGY, v.28, n.3, p.264-268, 2008
dc.identifier0919-6544
dc.identifierhttp://producao.usp.br/handle/BDPI/27702
dc.identifier10.1111/j.1440-1789.2007.00871.x
dc.identifierhttp://dx.doi.org/10.1111/j.1440-1789.2007.00871.x
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1624346
dc.description.abstractThe Western blot technique is currently the standard detection method for suspected limb girdle muscular dystrophy (LGMD) 2A (calpainopathy). This is the first report in the English literature of the successful application of immunohistochemical techniques to support a diagnosis of LGMD 2A. This approach is straightforward and appears to be reasonably specific. We propose that immunohistochemical methods should be re-evaluated for the screening of undiagnosed patients with suspected LGMD 2A.
dc.languageeng
dc.publisherWILEY-BLACKWELL
dc.relationNeuropathology
dc.rightsCopyright WILEY-BLACKWELL
dc.rightsrestrictedAccess
dc.subjectcalpain-3
dc.subjectimmunohistochemistry
dc.subjectlimb girdle muscular dystrophy 2A
dc.subjectmyopathy
dc.subjectWestern blot
dc.titleDiagnosis of limb-girdle muscular dystrophy 2A by immunohistochemical techniques
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución